(Q40633203)

22 September 2017

title

CC chemokine ligand 2 and its receptor regulate mucosal production of IL-12 and TGF-beta in high dose oral tolerance (English)

1 reference

22 September 2017

CC Chemokine Ligand 2 and Its Receptor Regulate Mucosal Production of IL-12 and TGF-β in High Dose Oral Tolerance (English)

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

12 March 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

12 March 2024

2

Barrett J Rollins

1 reference

22 September 2017

William Kuziel

3

1 reference

22 September 2017

R. William DePaolo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14500652

12 March 2024

William J. Karpus

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14500652

12 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

22 September 2017

published in

Journal of Immunology

1 reference

22 September 2017

volume

171

1 reference

22 September 2017

issue

7

1 reference

22 September 2017

page(s)

3560-3567

1 reference

Peripheral selection of the T cell repertoire

22 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation

12 March 2024

4

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Human Peyer's patch T cells are sensitized to dietary antigen and display a Th cell type 1 cytokine profile

12 March 2024

5

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Antigen-driven peripheral immune tolerance. Suppression of organ-specific autoimmune diseases by oral administration of autoantigens

12 March 2024

6

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens

12 March 2024

7

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Mechanisms of peripheral T cell tolerance

12 March 2024

8

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells

12 March 2024

11

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Inductive events in oral tolerance in the TCR transgenic adoptive transfer model

12 March 2024

12

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes

12 March 2024

13

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Interleukin-10-secreting Peyer's patch cells are responsible for active suppression in low-dose oral tolerance

12 March 2024

14

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Mucosal tolerance is associated with, but independent of, up-regulation Th2 responses

12 March 2024

15

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines

12 March 2024

16

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

The role of chemokines in oral tolerance. Abrogation of nonresponsiveness by treatment with antimonocyte chemotactic protein-1

12 March 2024

17

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Properties of the novel proinflammatory supergene "intercrine" cytokine family.

12 March 2024

18

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Chemokines: new ligands, receptors and activities

12 March 2024

19

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

The nomenclature of chemokines.

12 March 2024

20

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Selective G protein coupling by C-C chemokine receptors

12 March 2024

21

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Cloning and functional expression of mCCR2, a murine receptor for the C-C chemokines JE and FIC

12 March 2024

22

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant

12 March 2024

24

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production

12 March 2024

27

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion

12 March 2024

28

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures

12 March 2024

29

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1

12 March 2024

30

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

T cell receptor antagonist peptides induce positive selection

12 March 2024

32

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease

12 March 2024

33

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

The role of macrophage inflammatory protein 1 alpha in Schistosoma mansoni egg-induced granulomatous inflammation

12 March 2024

35

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment.

12 March 2024

36

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Oral administration of myelin induces antigen-specific TGF-beta 1 secreting T cells in patients with multiple sclerosis

12 March 2024

37

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Oral Tolerance to Myelin Basic Protein Induces Regulatory TGF-β-Secreting T Cells in Peyer's Patches of SJL Mice

12 March 2024

39

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation

12 March 2024

40

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Adenoviral-mediated overexpression of monocyte chemoattractant protein-1 differentially alters the development of Th1 and Th2 type responses in vivo

12 March 2024

41

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

CTLA-4 is required for the induction of high dose oral tolerance.

12 March 2024

43

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

History of oral tolerance and mucosal immunity

12 March 2024

44

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Induction of low dose oral tolerance in monocyte chemoattractant protein-1- and CCR2-deficient mice

12 March 2024

46

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice

12 March 2024

47

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

A mechanism for the impaired IFN-gamma production in C-C chemokine receptor 2 (CCR2) knockout mice: role of CCR2 in linking the innate and adaptive immune responses.

12 March 2024

48

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation

12 March 2024

49

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

TGF-beta downmodulates cytokine-induced monocyte chemoattractant protein (MCP)-1 expression in human endothelial cells. A putative role for TGF-beta in the modulation of TNF receptor expression

12 March 2024

50

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors

12 March 2024

51

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling

12 March 2024

52

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10.

12 March 2024

54

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Transforming growth factor beta: a matter of life and death

12 March 2024

55

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

TGF-beta in the evolution and resolution of inflammatory and immune processes. Introduction

12 March 2024

56

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta

12 March 2024

57

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Transforming growth factor beta from multiple myeloma cells inhibits proliferation and IL-2 responsiveness in T lymphocytes

12 March 2024

58

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

Antigen-specific, CD4+CD25+ regulatory T cell clones induced in Peyer's patches

12 March 2024

59

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3560

12 March 2024

Identifiers

1 reference

22 September 2017

1 reference